Cure My Disease
Don't miss your cure!
Please sign in to follow a disease.
Clinical trials sponsored by Nexcella Inc., explained in plain language.
This study tests a new treatment called NXC-201 CAR-T for people with AL amyloidosis, a rare disease where abnormal proteins build up in organs. The therapy uses a patient's own immune cells, modified to target and destroy the cells producing these proteins. The trial is open to …
Phase: PHASE1, PHASE2 • Sponsor: Nexcella Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC